These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The R306G and R506Q mutations in coagulation Factor V reveals additional cleavage sites for Activated Protein C in the R313-R321 region and at R505. Dirven RJ, Vos HL, Bertina RM. Thromb Res; 2010 May; 125(5):444-50. PubMed ID: 20051284 [Abstract] [Full Text] [Related]
5. Carbohydrate moieties on the procofactor factor V, but not the derived cofactor factor Va, regulate its inactivation by activated protein C. Silveira JR, Kalafatis M, Tracy PB. Biochemistry; 2002 Feb 05; 41(5):1672-80. PubMed ID: 11814362 [Abstract] [Full Text] [Related]
8. The C-terminal region of the factor V B-domain is crucial for the anticoagulant activity of factor V. Thorelli E, Kaufman RJ, Dahlbäck B. J Biol Chem; 1998 Jun 26; 273(26):16140-5. PubMed ID: 9632668 [Abstract] [Full Text] [Related]
10. Molecular characterization of an extended binding site for coagulation factor Va in the positive exosite of activated protein C. Gale AJ, Tsavaler A, Griffin JH. J Biol Chem; 2002 Aug 09; 277(32):28836-40. PubMed ID: 12063259 [Abstract] [Full Text] [Related]
11. Prothrombin amino terminal region helps protect coagulation factor Va from proteolytic inactivation by activated protein C. Yegneswaran S, Nguyen PM, Gale AJ, Griffin JH. Thromb Haemost; 2009 Jan 09; 101(1):55-61. PubMed ID: 19132189 [Abstract] [Full Text] [Related]
12. Comparison of activated protein C/protein S-mediated inactivation of human factor VIII and factor V. Lu D, Kalafatis M, Mann KG, Long GL. Blood; 1996 Jun 01; 87(11):4708-17. PubMed ID: 8639840 [Abstract] [Full Text] [Related]
13. Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C. Nicolaes GA, Tans G, Thomassen MC, Hemker HC, Pabinger I, Varadi K, Schwarz HP, Rosing J. J Biol Chem; 1995 Sep 08; 270(36):21158-66. PubMed ID: 7673148 [Abstract] [Full Text] [Related]
14. The roles of factor Va and protein S in formation of the activated protein C/protein S/factor Va inactivation complex. Gierula M, Salles-Crawley II, Santamaria S, Teraz-Orosz A, Crawley JTB, Lane DA, Ahnström J. J Thromb Haemost; 2019 Dec 08; 17(12):2056-2068. PubMed ID: 31364267 [Abstract] [Full Text] [Related]
15. Detailed mechanisms of the inactivation of factor VIIIa by activated protein C in the presence of its cofactors, protein S and factor V. Gale AJ, Cramer TJ, Rozenshteyn D, Cruz JR. J Biol Chem; 2008 Jun 13; 283(24):16355-62. PubMed ID: 18424440 [Abstract] [Full Text] [Related]
16. Characterization of a factor Xa binding site on factor Va near the Arg-506 activated protein C cleavage site. Gale AJ, Yegneswaran S, Xu X, Pellequer JL, Griffin JH. J Biol Chem; 2007 Jul 27; 282(30):21848-55. PubMed ID: 17553804 [Abstract] [Full Text] [Related]
17. Novel APC-cleavage sites in FVa provide insights into mechanisms of action of APC and its cofactor protein S. Tran S, Dahlbäck B. J Thromb Haemost; 2010 Jan 27; 8(1):129-36. PubMed ID: 19874463 [Abstract] [Full Text] [Related]
18. The second laminin G-type domain of protein S is indispensable for expression of full cofactor activity in activated protein C-catalysed inactivation of factor Va and factor VIIIa. Evenäs P, García de Frutos P, Nicolaes GA, Dahlbäck B. Thromb Haemost; 2000 Aug 27; 84(2):271-7. PubMed ID: 10959700 [Abstract] [Full Text] [Related]
19. Enhanced rate of cleavage at Arg-306 and Arg-506 in coagulation factor Va by Gla domain-mutated human-activated protein C. Sun YH, Tran S, Norstrøm EA, Dahlbäck B. J Biol Chem; 2004 Nov 12; 279(46):47528-35. PubMed ID: 15337738 [Abstract] [Full Text] [Related]